Pharmaceutical Research and Manufacturers of America California Initiative Fund

View

Source Type	Distribution	Amount	Percentage
Other		$81.8M	100.0%
Total		$81.8M	100%

Itemized Group by Donor

Donor	Total Amount	% of Total
Pfizer, Inc. Other	~$X,XXX,XXX	12.4%
Merck & Co., Inc. Other	~$X,XXX,XXX	12.1%
Johnson & Johnson Other	~$X,XXX,XXX	12.1%
Glaxosmithkline Other	~$X,XXX,XXX	12.0%
Amgen Inc. Other	~$X,XXX,XXX	5.7%
Abbott Laboratories Other	~$X,XXX,XXX	5.6%
Novartis Pharmaceuticals Corporation Other	~$X,XXX,XXX	5.6%
Eli Lilly and Company Other	~$X,XXX,XXX	5.6%
Astrazeneca Lp Other	~$X,XXX,XXX	5.6%
Aventis Pharmaceuticals, Inc. Other	~$X,XXX,XXX	5.6%
Bristol-Myers Squibb Company Other	~$X,XXX,XXX	5.6%
Wyeth Other	~$X,XXX,XXX	5.6%
Schering Corporation Other	~$XXX,XXX	1.0%
Hoffman-La Roche Inc. Other	~$XXX,XXX	1.0%
Boehringer Ingelheim Pharmaceuticals Other	~$XXX,XXX	1.0%
Serono, Inc. Other	~$XXX,XXX	0.5%
Bayer Corporation Other	~$XXX,XXX	0.3%
Sepracor Other	~$XXX,XXX	0.3%
Schwarz Pharma Other	~$XXX,XXX	0.3%
Organon Usa Inc. Other	~$XXX,XXX	0.3%
Bank of America Other	~$XXX,XXX	0.3%
Astellas Us Llc Other	~$XXX,XXX	0.3%
Michael D. Meyers Co., Inc. Other	~$XXX,XXX	0.2%
Gcw Media Services Other	~$XXX,XXX	0.2%
Valeant Pharmaceutical, Inc. Other	~$XXX,XXX	0.2%

Page 1 of 2